Norland receives PMA for ultrasound bone unit

Article

Bone densitometry vendor Norland Medical Systems and its partner, U.K.-based McCue, have received premarket approval clearance from the Food and Drug Administration for CubaClinical, an ultrasound bone measurement system. CubaClinical is a dry system and

Bone densitometry vendor Norland Medical Systems and its partner, U.K.-based McCue, have received premarket approval clearance from the Food and Drug Administration for CubaClinical, an ultrasound bone measurement system. CubaClinical is a dry system and carries a large clinical database, according to Norland executives.

After terminating a two-year alliance with Canadian firm IMRO, White Plains, NY-based Norland signed an exclusive distribution and service agreement in June 1999 with McCue, which developed CubaClinical (SCAN 8/4/99). Norland distributes McCue systems in the U.S., Canada, Europe, Africa, the Middle East, and the Pacific Rim. CubaClinical lists at approximately $20,000.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.